NCT00003445已完成2 期
Neoadjuvant Chemotherapy With Docetaxel in Advanced Cervical Carcinoma
Grupo Oncologico Cooperativo del Sur2 个研究点 分布在 1 个国家开始时间: 1997年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with advanced cancer of the cervix.
详细描述
OBJECTIVES: I. Assess the antitumor activity of docetaxel as neoadjuvant chemotherapy in patients with locally advanced squamous cell carcinoma of the cervix. II. Assess the tumor response, toxic effect, and survival rate of this regimen in these patients.
OUTLINE: Patients receive docetaxel IV over 1 hour on day 1. Treatment is repeated every 3 weeks for 3 courses. Patients are followed every 3 months posttreatment.
PROJECTED ACCRUAL: A total of 16-35 patients will be accrued for this study.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •DISEASE CHARACTERISTICS: Histologically proven stage IIB, IIIA, IIIB, and IVA squamous cell carcinoma of the cervix Bidimensionally measurable disease No bilateral hydronefrosis
- •PATIENT CHARACTERISTICS: Age: Any age Performance status: WHO 0-2 Life expectancy: At least 12 weeks Hematopoietic: Hemoglobin at least 10 g/dL Leukocytes at least 4,000/mm3 Platelet count at least 75,000/mm3 Hepatic: Bilirubin less than 1.25 times upper limit of normal (ULN) AST less than 1.25 times ULN Renal: BUN less than 30 mg/dL AND Creatinine less than 1.5 mg/dL OR Creatinine clearance at least 60 mL/min Other: No prior or other concurrent malignancies, other than properly treated basal cell skin cancer
- •PRIOR CONCURRENT THERAPY: Not specified
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate CancerProstate CancerNCT00017563OHSU Knight Cancer Institute57
已完成
1 期
Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung CancerLung CancerNCT00003037Memorial Sloan Kettering Cancer Center
Unknown
3 期
Docetaxel in Treating Patients With Non-Small Cell Lung CancerLung CancerNCT00022022Istituto Nazionale per lo Studio e la Cura dei Tumori200
已完成
1 期
Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerBreast CancerNCT00020332National Cancer Institute (NCI)
已完成
3 期
Docetaxel in Treating Patients With Metastatic Breast CancerBreast CancerNCT00008411M.D. Anderson Cancer Center90